Diseases, Conditions, Syndromes

Wegovy cuts heart risks by 20% in large trial

In a finding that could change the landscape of heart disease care, the wildly popular weight-loss drug Wegovy has proved its mettle in protecting the heart after lowering the risk of cardiac problems in patients by 20%.

Medications

US approves highly anticipated Eli Lilly weight loss drug

The US Food and Drug Administration (FDA) on Wednesday announced it had approved Eli Lilly's highly anticipated weight loss drug Zepbound, the latest entrant in a field of powerful—and lucrative—new obesity medicines.

Health

US hospitals turn to gig platforms on nurse shortage

When Jessica Martinez moved away from home in 2020, a temporary contract brought her to New Jersey as a nurse on the frontlines of the pandemic. But her earnings slipped as COVID-19 faded.

page 13 from 40